| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f4a75c831b48f9ba803dd403081a8a9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-58 |
| filingDate |
2004-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6059494ee099a8503fca041f2352f04c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00feadccfcaae3ad7eb9131a8e58fcb7 |
| publicationDate |
2006-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1657232-A1 |
| titleOfInvention |
Use of S-enantiomers of alpha-sustituted aryl acetic acids for the prevention of Alzheimer's disease |
| abstract |
The present invention relates to a novel class of y-secretase inhibitors, including pharmaceutically acceptable salts thereof, which are useful as therapeutic compounds, particularly in the treatment of Alzheimer's disease. The present invention also relates to a process for preparing said compounds as well as a process for the identification of such compounds. |
| priorityDate |
2004-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |